Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined.Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Participants who met one of th...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Peter G. Gibson, Ian A. Yang, John W. Upham, Paul N. Reynolds, Sandra Hodge, Alan L. James, Christine Jenkins, Matthew Peters, Guy B. Marks, Melissa Baraket, Heather Powell, Jodie L. Simpson
Materialtyp: Artigo
Språk:engelska
Publicerad: 2019
Länkar:https://doi.org/10.1183/23120541.00056-2019
https://openres.ersjournals.com/content/erjor/5/4/00056-2019.full.pdf
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!